Just Give Me Positive Good News
  • Home
  • Good News
  • Home
  • Good News

JUST POSITIVE GOOD NEWS ABOUT COVID-19

There is so much negativity in the news about COVID-19, we want to give you all the positive good news that is happening with research, clinical trials, improvements and anything that we can be positive about that you may not have seen.

IF YOU JUST WANT FEEL GOOD, INSPIRING STORIES AND VIDEOS THEN LOOK AT OUR NEW PAGE HERE

Moderna: 'We're Ready' To Ship 20 Million Coronavirus Vaccine Doses By The End Of 2020

10/30/2020

 
The third and final clinical trial for Moderna’s coronavirus vaccine is still underway, but the company is already setting an aggressive schedule to manufacture and ship the vaccine immediately if the Food and Drug Administration approves it.

“By the end of this year, we expect to have approximately 20 million doses ready to ship in the U.S.,” Moderna chief medical officer Dr. Tal Zaks said at an investor briefing on Thursday. “From a distribution standpoint, we’re ready.”

The company has also agreed to supply several other countries including Japan, Canada, Switzerland, Israel and Qatar with tens of millions of doses, Zaks said. By the end of 2021, the company hopes to supply the world with up to a billion doses – or 500 million full courses of the two-dose vaccine.

But that hinges on whether the FDA and the equivalent regulatory agencies of other countries approve Moderna’s product, which is built on a new and untried vaccine technology. Moderna’s vaccine uses RNA, a type of genetic code that also served as the inspiration for Moderna’s name – a portmanteau of the words Mode and RNA. This genetic code instructs human cells to produce a coronavirus protein. The body’s immune system then generates a defensive response to that protein.

The ongoing third clinical trial for the vaccine will determine if that immune response is enough to protect against coronavirus infection. Until the results of that trial are out, there's no saying if the vaccine will really work.

According to the FDA, Zaks said, a final analysis of the clinical trial would need to show the vaccine is at least 50 percent effective for approval. But, he added, Moderna is setting a higher bar.

“In order to call it a success, we will need to show a vaccine efficacy of 74% or greater,” Zaks said during the investor meeting.

https://www.wbur.org/commonhealth/2020/10/29/moderna-vaccine-end-of-year

HELP US SPREAD GOOD NEWS!

I run this site in my spare time and thoroughly enjoy giving you all positive news!  If you've enjoyed the site we'd love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.

ENJOY FEEL GOOD, INSPIRING STORIES AND VIDEOS ?

Our new page here is just what you need, with just good news, feel good stories unrelated to COVID.

Comments are closed.

    Who Am I ?

    Just someone trying to highlight the positive news amongst a sea of negativity.


    Archives

    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020

    Categories

    All
    Australia
    Austria
    Brazil
    Canada
    China
    Clinical Trials
    Companies
    Denmark
    Education
    France
    Germany
    Greece
    India
    Ireland
    Italy
    Lockdown
    Netherlands
    New Zealand
    Portugal
    PPE
    Reopen
    South Korea
    Spain
    Statistics
    Summary
    Switzerland
    Testing
    Treatment
    Turkey
    UK
    USA
    Vaccine
    Ventilators

    RSS Feed

Proudly powered by Weebly